Long-term outcomes of benznidazole treatment in chronic Chagas disease: A 27-year cohort study of parasitological cure and death in the Jequitinhonha Valley, Brazil
PLOS Neglected Tropical Diseases · 2025
DOI: 10.1371/journal.pntd.0013619 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift PLOS Neglected Tropical Diseases, 2025. Verfasst von Júlio César Santoro de Oliveira Assis und 10 weiteren Autor:innen. Beteiligte Einrichtung: Programa de Pós-graduação em Ciências Biológicas, Núcleo de Pesquisa em Ciências Biológicas, Universidade Federal de Ouro Preto, Ouro Preto, Minas Ge…. Hauptthemen laut MEDLINE: Chagas Disease, Nitroimidazoles, Trypanocidal Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação de Amparo à Pesquisa do Estado de Minas Gerais (FAPEMIG), Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq), Fundação de Amparo à Pesquisa do Estado de Minas Gerais.
Abstract (Originalsprache)
Background
Chagas disease (CD) is a neglected tropical infection prevalent in rural areas of Latin America. The etiological treatment is indicated for patients with both acute and chronic phases of CD, except in the most advanced clinical stage of the disease. However, there are still several divergences regarding the benefits of etiological treatment in chronic CD as far as the parasitological cure and survival/mortality outcomes. The present study aimed at verifying the impact of benznidazole (BZ) treatment on parasitological cure and death of patients with chronic CD at 9, 13, and 27 years post-treatment.
Objective
This study aimed to verify the impact of BZ-treatment on parasitological cure and death of patients with chronic CD at 9, 13, and 27-year follow-up.
Methods
A historical and prospective cohort of 42 patients with chronic CD, categorized as BZ-treated (BZ-T, n = 21) and Not-treated (NT, n = 21), were evaluated after 9, 13, and 27 years of follow-up, using parasitological tests (Hemoculture-HC, polymerase chain reaction-PCR, and quantitative real-time PCR-qPCR), conventional-CS (ELISA), and non-conventional-NCS (Chagas-Flow ATE) serology, employing three distinct cure criteria, one classical and two alternative. Survival analysis for death was determined by the Kaplan-Meier method.
Results
Parasitological data (HC, PCR and qPCR) were negative in all patients (BZ-T and NT) at 27-year follow-up. The CS was negative in 75% and 23.1% of patients from BZ-T and NT, respectively. NCS had a higher negative rate (95%) than CS (23.1%) in BZ-T. The classic cure criterion demonstrated that 75% of BZ-T achieved a successful therapeutic outcome. Moreover, the use of the second and third alternative cure criteria revealed a higher proportion of cure in BZ-T (90%). The overall mortality over 27-year follow-up was 4.8% in BZ-T and 38.1% in NT. Kaplan-Meier survival curves for survival estimated 95% and 40% for BZ-T and NT patient groups.
Conclusions
The overall analysis demonstrated that BZ-T chronic CD patients yielded higher parasitological cure rates as well as increased survival over a 27-year follow-up. The Chagas-Flow ATE proved to be a valuable tool for monitoring therapeutic response and, together with parasitological and molecular parasitological methods, provided a more accurate cure criterion.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Programa de Pós-graduação em Ciências Biológicas, Núcleo de Pesquisa em Ciências Biológicas, Universidade Federal de Ouro Preto, Ouro Preto, Minas Gerais, Brazil.
- Programa de Pós-Graduação em Ciências Farmacêuticas, Escola de Farmácia, Universidade Federal de Ouro Preto, Ouro Preto, Minas Gerais, Brazil.
- Departamento de Ciências Básicas da Vida, Universidade Federal de Juiz de Fora, Campus Governador Valadares, Governador Valadares, Minas Gerais, Brazil.
- Universidade Federal dos Vales do Jequitinhonha e Mucuri, Diamantina, Minas Gerais, Brazil.
- Grupo Integrado de Pesquisas em Biomarcadores, Instituto René Rachou/FIOCRUZ-Minas, Belo Horizonte, Minas Gerais, Brazil.
- Hospital Nossa Senhora das Graças, Sete Lagoas, Minas Gerais, Brazil.
ORCID-Profile: Marta de Lana
Förderung
- Fundação de Amparo à Pesquisa do Estado de Minas Gerais (FAPEMIG)
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)
- Fundação de Amparo à Pesquisa do Estado de Minas Gerais
- Conselho Nacional de Desenvolvimento CientÃfico e Tecnológico
- Coordenação de Aperfeiçoamento de Pessoal de NÃvel Superior
Zitieren
APA
Assis, J. C. S. O., Suave, L. T., Fernandes, G. R. R., Machado-de-Assis, G. F., Martins, H. R., Alessio, G. D., Martins-Filho, O. A., Salgado, R. A., Carneiro, M., Torres, R. M., & de Lana, M. (2025). Long-term outcomes of benznidazole treatment in chronic Chagas disease: A 27-year cohort study of parasitological cure and death in the Jequitinhonha Valley, Brazil. PLOS Neglected Tropical Diseases. https://doi.org/10.1371/journal.pntd.0013619
Vancouver
Assis JCSO, Suave LT, Fernandes GRR, Machado-de-Assis GF, Martins HR, Alessio GD, et al. Long-term outcomes of benznidazole treatment in chronic Chagas disease: A 27-year cohort study of parasitological cure and death in the Jequitinhonha Valley, Brazil. PLOS Neglected Tropical Diseases. 2025. doi:10.1371/journal.pntd.0013619
BibTeX
@article{Assis2025,
author = {Assis, Júlio César Santoro de Oliveira and Suave, Lourena Tomazelli and Fernandes, Gabriela Roberta Ramos and Machado-de-Assis, Girley Francisco and Martins, Helen Rodrigues and Alessio, Glaucia Diniz and Martins-Filho, Olindo Assis and Salgado, Renato Afonso and Carneiro, Mariângela and Torres, Rosália Morais and de Lana, Marta},
title = {Long-term outcomes of benznidazole treatment in chronic Chagas disease: A 27-year cohort study of parasitological cure and death in the Jequitinhonha Valley, Brazil},
journal = {PLOS Neglected Tropical Diseases},
year = {2025},
doi = {10.1371/journal.pntd.0013619}
}
EUVIMED